Polycystic Ovarian Syndrome; A Clinician’s Perspective |Biomedgrid

Polycystic Ovarian Syndrome (PCO) is a conglomerate of different predisposing factors, such as infertility, bleeding disorders, diabetes, hypertension etc. which more than 15% of the female population suffers from and seems to increase in prevalence [1]. Moreover, in menopause this condition is not over, as the resulting diabetes, cardiovascular risk, metabolic syndrome etc. will remain an influencing factor in the life in these women. Many factors including genetic susceptibility, maternal milieu, and postnatal environment are likely to synergize in the development of the different PCO conditions. This Presentation Discusses the Following: Genetics in PCO, factors enabling to induce PCO conditions such as the two-hit hypothesis drawing the attention to prenatal and postnatal possible impact. Based on this consideration suggestions for proposed treatments and strategies for ameliorating the PCO now and in the future is presented.